The combination of valproic acid, all-trans retinoic acid and low-dose cytarabine as disease-stabilizing treatment in acute myeloid leukemia

BACKGROUND: A large proportion of patients with acute myeloid leukemia (AML) are not fit for intensive and potentially curative therapy due to advanced age or comorbidity. Previous studies have demonstrated that a subset of these patients can benefit from disease-stabilizing therapy based on all-tra...

Descripción completa

Detalles Bibliográficos
Autores principales: Fredly, Hanne, Ersvær, Elisabeth, Kittang, Astrid Olsnes, Tsykunova, Galina, Gjertsen, Bjørn Tore, Bruserud, Øystein
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3765924/
https://www.ncbi.nlm.nih.gov/pubmed/23915396
http://dx.doi.org/10.1186/1868-7083-5-13

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3765924/
https://www.ncbi.nlm.nih.gov/pubmed/23915396
http://dx.doi.org/10.1186/1868-7083-5-13

Ejemplares similares